AG 1478

AG 1478__EGFR kinase inhibitor Rucaparib (phosphate)

Product Name AG 1478
Description

EGFR kinase inhibitor

Purity >98% (HPLC)
CAS No. 153436-53-4
Molecular Formula C16H14ClN3O2
Molecular Weight 315.8
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO (10 mg/ml)
Source Synthetic
Appearance White to light yellow solid
SMILES COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Cl)OC
InChI InChI=1S/C16H14ClN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)
InChIKey GFNNBHLJANVSQV-UHFFFAOYSA-N
Safety Phrases Classification:
Not a hazardous substance or mixture.

Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.

Cite This Product AG 1478 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-425)

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19112019

Alternative Names N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine, 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline
Research Areas Cancer, Apoptosis, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors
PubChem ID 2051
Scientific Background AG 1478 is a potent and selective inhibitor of EGFR. It does so by reducing EGF-stimulated DNA synthesis (seen in rat fibroblasts) and blocking EGF-dependent src-family kinase activation and p21/Cip 1/WAF1 induction (seen in A431 cells). AG 1478 is cell-permeable and active in vivo.
References 1. Osherov N., & Levitzki A. (1994) Euro J. Biochem. 225(3): 1047–1053.
2. Miyazaki Y., et al. (1996) Biochem. Biophys. Research Comm. 226(2): 542–546.
3. Fan Z., et al. (1995) J Cell Biol. 131(1): 235–242.